高磷血症-话题@MedSci

#高磷血症#

8篇内容 | 1527人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2249123, encodeId=96082249123c4, content=<a href='/topic/show?id=f6f5536422e' target=_blank style='color:#2F92EE;'>#慢性肾病#</a> <a href='/topic/show?id=27491025330f' target=_blank style='color:#2F92EE;'>#高磷血症#</a> <a href='/topic/show?id=ef1d898002a' target=_blank style='color:#2F92EE;'>#血管钙化#</a>, objectTitle=南方医科大学Science子刊：生物模拟皱褶型益生元微球用于慢性肾病高磷血症和血管钙化的治疗, objectType=article, longId=860473, objectId=de428604e394, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240510/1715353279363_5579292.png, objectUrl=/article/show_article.do?id=de428604e394, replyNumber=0, likeNumber=27, createdTime=2025-01-21, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=de428604e394, moduleTitle=南方医科大学Science子刊：生物模拟皱褶型益生元微球用于慢性肾病高磷血症和血管钙化的治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=de428604e394)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2233253, encodeId=ed102233253fe, content=<a href='/topic/show?id=bfe710950042' target=_blank style='color:#2F92EE;'>#终末期肾病（ESRD）#</a> <a href='/topic/show?id=27491025330f' target=_blank style='color:#2F92EE;'>#高磷血症#</a>, objectTitle=Tenapanor在终末期肾病患者高磷血症中的疗效和安全性, objectType=article, longId=848600, objectId=c0f9848600c8, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202401025/1729867551697_5121051.png, objectUrl=/article/show_article.do?id=c0f9848600c8, replyNumber=0, likeNumber=47, createdTime=2024-10-26, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=c0f9848600c8, moduleTitle=Tenapanor在终末期肾病患者高磷血症中的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c0f9848600c8)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2196901, encodeId=92e82196901cd, content=<a href='/topic/show?id=27491025330f' target=_blank style='color:#2F92EE;'>#高磷血症#</a> <a href='/topic/show?id=552311305e14' target=_blank style='color:#2F92EE;'>#钠/氢交换体3 (NHE3)的选择性抑制剂#</a>, objectTitle=Clin Exp Nephrol：Tenapanor治疗日本腹膜透析患者高磷血症的疗效与安全性, objectType=article, longId=820198, objectId=c828820198b2, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202301012/1697149625181_4754896.jpeg, objectUrl=/article/show_article.do?id=c828820198b2, replyNumber=0, likeNumber=157, createdTime=2024-04-04, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=c828820198b2, moduleTitle=Clin Exp Nephrol：Tenapanor治疗日本腹膜透析患者高磷血症的疗效与安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c828820198b2)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1662835, encodeId=f1bd1662835c5, content=<a href='/topic/show?id=27491025330f' target=_blank style='color:#2F92EE;'>#高磷血症#</a>, objectTitle=新型磷结合剂「碳酸司维拉姆」在华获批又一适应证，为非透析慢性肾脏病高磷血症人群提供治疗新选择, objectType=article, longId=219666, objectId=256921966684, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=256921966684, replyNumber=0, likeNumber=92, createdTime=2022-04-28, rootId=0, userName=12498877m106暂无昵称, userId=2c4725514725, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=256921966684, moduleTitle=新型磷结合剂「碳酸司维拉姆」在华获批又一适应证，为非透析慢性肾脏病高磷血症人群提供治疗新选择, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=256921966684)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1662834, encodeId=a34f166283496, content=<a href='/topic/show?id=27491025330f' target=_blank style='color:#2F92EE;'>#高磷血症#</a>, objectTitle=JAMA：碳酸镧 vs 碳酸钙对高磷血症患者血管钙化相关心血管事件风险的影响, objectType=article, longId=211559, objectId=a814211559f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a814211559f9, replyNumber=0, likeNumber=150, createdTime=2022-04-11, rootId=0, userName=12498877m106暂无昵称, userId=2c4725514725, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a814211559f9, moduleTitle=JAMA：碳酸镧 vs 碳酸钙对高磷血症患者血管钙化相关心血管事件风险的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a814211559f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1662833, encodeId=8b3e166283386, content=<a href='/topic/show?id=27491025330f' target=_blank style='color:#2F92EE;'>#高磷血症#</a>, objectTitle=高磷血症药！百美特生物「醋酸钙片」首家通过一致性评价, objectType=article, longId=202181, objectId=a7c6202181f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a7c6202181f3, replyNumber=0, likeNumber=134, createdTime=2021-07-23, rootId=0, userName=12498877m106暂无昵称, userId=2c4725514725, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a7c6202181f3, moduleTitle=高磷血症药！百美特生物「醋酸钙片」首家通过一致性评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a7c6202181f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1662832, encodeId=35151662832dd, content=<a href='/topic/show?id=27491025330f' target=_blank style='color:#2F92EE;'>#高磷血症#</a>, objectTitle=Eur Urol：继发于选择性成纤维细胞生长因子受体1-3抑制剂Infigratinib（BGJ398）的高磷血症与成纤维细胞生长因子受体3变异的晚期/转移性尿路癌的抗肿瘤疗效有关 , objectType=article, longId=200106, objectId=c2aa200106d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c2aa200106d4, replyNumber=0, likeNumber=157, createdTime=2021-05-02, rootId=0, userName=12498877m106暂无昵称, userId=2c4725514725, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c2aa200106d4, moduleTitle=Eur Urol：继发于选择性成纤维细胞生长因子受体1-3抑制剂Infigratinib（BGJ398）的高磷血症与成纤维细胞生长因子受体3变异的晚期/转移性尿路癌的抗肿瘤疗效有关 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c2aa200106d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1662831, encodeId=043b1662831ba, content=<a href='/topic/show?id=27491025330f' target=_blank style='color:#2F92EE;'>#高磷血症#</a>, objectTitle=Ardelyx的实验性药物Tenapanor达到了高磷血症的第二个III期研究的主要目标, objectType=article, longId=184167, objectId=053a18416e94, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=053a18416e94, replyNumber=0, likeNumber=139, createdTime=2020-01-26, rootId=0, userName=12498877m106暂无昵称, userId=2c4725514725, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=053a18416e94, moduleTitle=Ardelyx的实验性药物Tenapanor达到了高磷血症的第二个III期研究的主要目标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=053a18416e94)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1662830, encodeId=247216628303a, content=<a href='/topic/show?id=27491025330f' target=_blank style='color:#2F92EE;'>#高磷血症#</a>, objectTitle=Ardelyx的钠/氢交换异构体抑制剂tenapanor符合高磷血症的III期研究的主要终点, objectType=article, longId=178809, objectId=55521e880970, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=55521e880970, replyNumber=0, likeNumber=155, createdTime=2020-02-15, rootId=0, userName=12498877m106暂无昵称, userId=2c4725514725, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=55521e880970, moduleTitle=Ardelyx的钠/氢交换异构体抑制剂tenapanor符合高磷血症的III期研究的主要终点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=55521e880970)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1662829, encodeId=af6216628298a, content=<a href='/topic/show?id=27491025330f' target=_blank style='color:#2F92EE;'>#高磷血症#</a>, objectTitle=FDA批准Velphoro治疗慢性肾脏病透析患者高磷血症, objectType=article, longId=27431, objectId=90d32e4316f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=90d32e4316f, replyNumber=0, likeNumber=151, createdTime=2014-07-13, rootId=0, userName=12498877m106暂无昵称, userId=2c4725514725, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=90d32e4316f, moduleTitle=FDA批准Velphoro治疗慢性肾脏病透析患者高磷血症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=90d32e4316f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1662828, encodeId=60e116628289c, content=<a href='/topic/show?id=27491025330f' target=_blank style='color:#2F92EE;'>#高磷血症#</a>, objectTitle=高频血透可有效控制高磷血症, objectType=article, longId=5129, objectId=4298512991, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4298512991, replyNumber=0, likeNumber=177, createdTime=2013-02-04, rootId=0, userName=12498877m106暂无昵称, userId=2c4725514725, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4298512991, moduleTitle=高频血透可有效控制高磷血症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4298512991)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

高磷血症

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#慢性肾病# #高磷血症# #血管钙化#

南方医科大学Science子刊：生物模拟皱褶型益生元微球用于慢性肾病高磷血症和血管钙化的治疗

2025-01-21发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#终末期肾病（ESRD）# #高磷血症#

Tenapanor在终末期肾病患者高磷血症中的疗效和安全性

2024-10-26发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#高磷血症# #钠/氢交换体3 (NHE3)的选择性抑制剂#

Clin Exp Nephrol：Tenapanor治疗日本腹膜透析患者高磷血症的疗效与安全性

2024-04-04发表于上海

12498877m106暂无昵称 (审核中...)

前往app查看评论内容

#高磷血症#

新型磷结合剂「碳酸司维拉姆」在华获批又一适应证，为非透析慢性肾脏病高磷血症人群提供治疗新选择

2022-04-28

12498877m106暂无昵称 (审核中...)

前往app查看评论内容

#高磷血症#

JAMA：碳酸镧 vs 碳酸钙对高磷血症患者血管钙化相关心血管事件风险的影响

2022-04-11

12498877m106暂无昵称 (审核中...)

前往app查看评论内容

#高磷血症#

高磷血症药！百美特生物「醋酸钙片」首家通过一致性评价

2021-07-23

12498877m106暂无昵称 (审核中...)

前往app查看评论内容

#高磷血症#

Eur Urol：继发于选择性成纤维细胞生长因子受体1-3抑制剂Infigratinib（BGJ398）的高磷血症与成纤维细胞生长因子受体3变异的晚期/转移性尿路癌的抗肿瘤疗效有关

2021-05-02

12498877m106暂无昵称 (审核中...)

前往app查看评论内容

#高磷血症#

Ardelyx的实验性药物Tenapanor达到了高磷血症的第二个III期研究的主要目标

2020-01-26

12498877m106暂无昵称 (审核中...)

前往app查看评论内容

#高磷血症#

Ardelyx的钠/氢交换异构体抑制剂tenapanor符合高磷血症的III期研究的主要终点

2020-02-15

12498877m106暂无昵称 (审核中...)

前往app查看评论内容

#高磷血症#

FDA批准Velphoro治疗慢性肾脏病透析患者高磷血症

2014-07-13

12498877m106暂无昵称 (审核中...)

前往app查看评论内容

#高磷血症#

高频血透可有效控制高磷血症

2013-02-04

科室
- - 订阅+
  - 更多科室
工具
服务